BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 36806874)

  • 1. Correction to 'An intellectual disability-related MED23 mutation dysregulates gene expression by altering chromatin conformation and enhancer activities'.
    Nucleic Acids Res; 2023 Mar; 51(5):2499. PubMed ID: 36806874
    [No Abstract]   [Full Text] [Related]  

  • 2. An intellectual disability-related MED23 mutation dysregulates gene expression by altering chromatin conformation and enhancer activities.
    Yang Y; Li C; Chen Z; Zhang Y; Tian Q; Sun M; Zhang S; Yu M; Wang G
    Nucleic Acids Res; 2023 Mar; 51(5):2137-2150. PubMed ID: 36718943
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MED23 mutation links intellectual disability to dysregulation of immediate early gene expression.
    Hashimoto S; Boissel S; Zarhrate M; Rio M; Munnich A; Egly JM; Colleaux L
    Science; 2011 Aug; 333(6046):1161-3. PubMed ID: 21868677
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MED23-associated refractory epilepsy successfully treated with the ketogenic diet.
    Lionel AC; Monfared N; Scherer SW; Marshall CR; Mercimek-Mahmutoglu S
    Am J Med Genet A; 2016 Sep; 170(9):2421-5. PubMed ID: 27311965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mediator MED23 Links Pigmentation and DNA Repair through the Transcription Factor MITF.
    Xia M; Chen K; Yao X; Xu Y; Yao J; Yan J; Shao Z; Wang G
    Cell Rep; 2017 Aug; 20(8):1794-1804. PubMed ID: 28834744
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mediator Med23 deficiency enhances neural differentiation of murine embryonic stem cells through modulating BMP signaling.
    Zhu W; Yao X; Liang Y; Liang D; Song L; Jing N; Li J; Wang G
    Development; 2015 Feb; 142(3):465-76. PubMed ID: 25564654
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Mediator subunit MED23 couples H2B mono-ubiquitination to transcriptional control and cell fate determination.
    Yao X; Tang Z; Fu X; Yin J; Liang Y; Li C; Li H; Tian Q; Roeder RG; Wang G
    EMBO J; 2015 Dec; 34(23):2885-902. PubMed ID: 26330467
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective requirement for Mediator MED23 in Ras-active lung cancer.
    Yang X; Zhao M; Xia M; Liu Y; Yan J; Ji H; Wang G
    Proc Natl Acad Sci U S A; 2012 Oct; 109(41):E2813-22. PubMed ID: 22988093
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MED23 in endocrinotherapy for breast cancer.
    Lin B; Zhang L; Li D; Sun H
    Oncol Lett; 2017 Jun; 13(6):4679-4684. PubMed ID: 28588722
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intellectual disability associated with craniofacial dysmorphism due to POLR3B mutation and defect in spliceosomal machinery.
    Saghi M; InanlooRahatloo K; Alavi A; Kahrizi K; Najmabadi H
    BMC Med Genomics; 2022 Apr; 15(1):89. PubMed ID: 35436926
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mediator MED23 plays opposing roles in directing smooth muscle cell and adipocyte differentiation.
    Yin JW; Liang Y; Park JY; Chen D; Yao X; Xiao Q; Liu Z; Jiang B; Fu Y; Bao M; Huang Y; Liu Y; Yan J; Zhu MS; Yang Z; Gao P; Tian B; Li D; Wang G
    Genes Dev; 2012 Oct; 26(19):2192-205. PubMed ID: 22972934
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Med23 serves as a gatekeeper of the myeloid potential of hematopoietic stem cells.
    Chen X; Zhao J; Gu C; Cui Y; Dai Y; Song G; Liu H; Shen H; Liu Y; Wang Y; Xing H; Zhu X; Hao P; Guo F; Liu X
    Nat Commun; 2018 Sep; 9(1):3746. PubMed ID: 30218073
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutations in the Mediator subunit MED23 link intellectual disability to immediate early gene regulation.
    Goh YS; Grants JM
    Clin Genet; 2012 May; 81(5):430. PubMed ID: 22129135
    [No Abstract]   [Full Text] [Related]  

  • 14. Mediator MED23 cooperates with RUNX2 to drive osteoblast differentiation and bone development.
    Liu Z; Yao X; Yan G; Xu Y; Yan J; Zou W; Wang G
    Nat Commun; 2016 Apr; 7():11149. PubMed ID: 27033977
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutations in the Chromatin Regulator Gene BRPF1 Cause Syndromic Intellectual Disability and Deficient Histone Acetylation.
    Yan K; Rousseau J; Littlejohn RO; Kiss C; Lehman A; Rosenfeld JA; Stumpel CTR; Stegmann APA; Robak L; Scaglia F; Nguyen TTM; Fu H; Ajeawung NF; Camurri MV; Li L; Gardham A; Panis B; Almannai M; Sacoto MJG; Baskin B; Ruivenkamp C; Xia F; Bi W; ; ; Cho MT; Potjer TP; Santen GWE; Parker MJ; Canham N; McKinnon M; Potocki L; MacKenzie JJ; Roeder ER; Campeau PM; Yang XJ
    Am J Hum Genet; 2017 Jan; 100(1):91-104. PubMed ID: 27939640
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Downregulation of MED23 promoted the tumorigenecity of esophageal squamous cell carcinoma.
    Shi J; Han Q; Zhao H; Zhong C; Yao F
    Mol Carcinog; 2014 Oct; 53(10):833-40. PubMed ID: 23625751
    [TBL] [Abstract][Full Text] [Related]  

  • 17. YY1 Haploinsufficiency Causes an Intellectual Disability Syndrome Featuring Transcriptional and Chromatin Dysfunction.
    Gabriele M; Vulto-van Silfhout AT; Germain PL; Vitriolo A; Kumar R; Douglas E; Haan E; Kosaki K; Takenouchi T; Rauch A; Steindl K; Frengen E; Misceo D; Pedurupillay CRJ; Stromme P; Rosenfeld JA; Shao Y; Craigen WJ; Schaaf CP; Rodriguez-Buritica D; Farach L; Friedman J; Thulin P; McLean SD; Nugent KM; Morton J; Nicholl J; Andrieux J; Stray-Pedersen A; Chambon P; Patrier S; Lynch SA; Kjaergaard S; Tørring PM; Brasch-Andersen C; Ronan A; van Haeringen A; Anderson PJ; Powis Z; Brunner HG; Pfundt R; Schuurs-Hoeijmakers JHM; van Bon BWM; Lelieveld S; Gilissen C; Nillesen WM; Vissers LELM; Gecz J; Koolen DA; Testa G; de Vries BBA
    Am J Hum Genet; 2017 Jun; 100(6):907-925. PubMed ID: 28575647
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mediator subunit 23 overexpression as a novel target for suppressing proliferation and tumorigenesis in hepatocellular carcinoma.
    Guo Y; Wang J; Li H; Liu W; Chen D; Zhao K; Liang X; Zhang Q; Yang Y; Chen G
    J Gastroenterol Hepatol; 2015 Jun; 30(6):1094-103. PubMed ID: 25684393
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liver Med23 ablation improves glucose and lipid metabolism through modulating FOXO1 activity.
    Chu Y; Gómez Rosso L; Huang P; Wang Z; Xu Y; Yao X; Bao M; Yan J; Song H; Wang G
    Cell Res; 2014 Oct; 24(10):1250-65. PubMed ID: 25223702
    [TBL] [Abstract][Full Text] [Related]  

  • 20. T-cells null for the MED23 subunit of mediator express decreased levels of KLF2 and inefficiently populate the peripheral lymphoid organs.
    Kasper LH; Fukuyama T; Brindle PK
    PLoS One; 2014; 9(7):e102076. PubMed ID: 25054639
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.